Literature DB >> 17109810

Angiotensin II induces phosphorylation of glucose-regulated protein-75 in WB rat liver cells.

Sharath B Krishna1, Lloyd F Alfonso, Thomas J Thekkumkara, Thomas J Abbruscato, G Jayarama Bhat.   

Abstract

Studies in vascular smooth muscle cells suggest that, angiotensin II (Ang II)-mediated cellular response requires transactivation of epidermal growth factor receptor (EGF-R), and involves tyrosine phosphorylation of caveolin-1. Here we demonstrate that, exposure of WB rat liver cells to Ang II does not cause transactivation of EGF-R, but did rapidly activate p42/p44 mitogen-activated protein (MAP) kinases suggesting that it activates MAP kinases independent of EGF-R transactivation. We observed that the phospho-specific anti-caveolin-1 antibody detected a tyrosine phosphorylated, 75kDa protein in Ang II-treated cells which we identified as glucose regulated protein-75 (GRP-75). Phosphoamino acid analysis showed that Ang II induced its phosphorylation at tyrosine, serine and threonine residues and was localized to the cytoplasm. The ability of Ang-II to induce GRP-75 phosphorylation suggests that it may play a role in the protection of cytoplasmic proteins from the damaging effect of oxidative stress known to be produced during Ang-II induced signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109810      PMCID: PMC2577571          DOI: 10.1016/j.abb.2006.10.011

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  57 in total

Review 1.  Liver fibrogenesis: a new role for the renin-angiotensin system.

Authors:  Ramón Bataller; Pau Sancho-Bru; Pere Ginès; David A Brenner
Journal:  Antioxid Redox Signal       Date:  2005 Sep-Oct       Impact factor: 8.401

2.  cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy.

Authors:  Masuko Ushio-Fukai; Lian Zuo; Satoshi Ikeda; Taiki Tojo; Nikolay A Patrushev; R Wayne Alexander
Journal:  Circ Res       Date:  2005-09-08       Impact factor: 17.367

3.  Activation of a novel calcium-dependent protein-tyrosine kinase. Correlation with c-Jun N-terminal kinase but not mitogen-activated protein kinase activation.

Authors:  H Yu; X Li; G S Marchetto; R Dy; D Hunter; B Calvo; T L Dawson; M Wilm; R J Anderegg; L M Graves; H S Earp
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

Review 4.  Epidermal growth factor.

Authors:  G Carpenter; S Cohen
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

5.  Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis.

Authors:  G Guo; J Morrissey; R McCracken; T Tolley; H Liapis; S Klahr
Journal:  Am J Physiol Renal Physiol       Date:  2001-05

6.  Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK.

Authors:  S Eguchi; P J Dempsey; G D Frank; E D Motley; T Inagami
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

Review 7.  Oxidant signaling in vascular cell growth, death, and survival : a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling.

Authors:  K Irani
Journal:  Circ Res       Date:  2000-08-04       Impact factor: 17.367

Review 8.  Redox signals that regulate the vascular response to injury.

Authors:  B C Berk
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

9.  Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt.

Authors:  S Eguchi; H Iwasaki; H Ueno; G D Frank; E D Motley; K Eguchi; F Marumo; Y Hirata; T Inagami
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

10.  Autophosphorylation sites on the epidermal growth factor receptor.

Authors:  J Downward; P Parker; M D Waterfield
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

View more
  2 in total

1.  A comparative proteomic study of nephrogenesis in intrauterine growth restriction.

Authors:  Qian Shen; Hong Xu; Li-Ming Wei; Jing Chen; Hai-Mei Liu; Wei Guo
Journal:  Pediatr Nephrol       Date:  2010-02-04       Impact factor: 3.714

Review 2.  Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease.

Authors:  Lili Sheng; George Bayliss; Shougang Zhuang
Journal:  Front Pharmacol       Date:  2021-01-26       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.